BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18306362)

  • 21. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
    Sachdev V; Kato GJ; Gibbs JS; Barst RJ; Machado RF; Nouraie M; Hassell KL; Little JA; Schraufnagel DE; Krishnamurti L; Novelli EM; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Castro OL; Taylor JG; Hannoush H; Goldsmith JC; Gladwin MT; Gordeuk VR;
    Circulation; 2011 Sep; 124(13):1452-60. PubMed ID: 21900080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension.
    Knight-Perry JE; de Las Fuentes L; Waggoner AD; Hoffmann RG; Blinder MA; Dávila-Román VG; Field JJ
    J Am Soc Echocardiogr; 2011 Nov; 24(11):1285-90. PubMed ID: 21873028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management.
    Aliyu ZY; Kato GJ; Taylor J; Babadoko A; Mamman AI; Gordeuk VR; Gladwin MT
    Am J Hematol; 2008 Jan; 83(1):63-70. PubMed ID: 17910044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hemodynamic study of pulmonary hypertension in sickle cell disease.
    Parent F; Bachir D; Inamo J; Lionnet F; Driss F; Loko G; Habibi A; Bennani S; Savale L; Adnot S; Maitre B; Yaïci A; Hajji L; O'Callaghan DS; Clerson P; Girot R; Galacteros F; Simonneau G
    N Engl J Med; 2011 Jul; 365(1):44-53. PubMed ID: 21732836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.
    Dahoui HA; Hayek MN; Nietert PJ; Arabi MT; Muwakkit SA; Saab RH; Bissar AN; Jumaa NM; Farhat FS; Dabbous IA; Bitar FF; Abboud MR
    Pediatr Blood Cancer; 2010 Mar; 54(3):398-402. PubMed ID: 19827138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.
    Forrest S; Kim A; Carbonella J; Pashankar F
    Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia.
    Peter ID; Asani MO; Abdullahi SU; Aliyu I; Obaro SK; Bode-Thomas F
    Trans R Soc Trop Med Hyg; 2019 Aug; 113(8):489-496. PubMed ID: 31086994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
    Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases.
    Haque AK; Gokhale S; Rampy BA; Adegboyega P; Duarte A; Saldana MJ
    Hum Pathol; 2002 Oct; 33(10):1037-43. PubMed ID: 12395378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
    Cabrita IZ; Mohammed A; Layton M; Ghorashian S; Gilmore A; Cho G; Howard J; Anie KA; Desforges L; Bassett P; Grapsa J; Howard L; Mahalingam G; Dawson D; Pinto FJ; Nihoyannopoulos P; Davies SC; Gibbs JS
    Br J Haematol; 2013 Aug; 162(3):400-8. PubMed ID: 23713628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.
    Lin EE; Rodgers GP; Gladwin MT
    Curr Hematol Rep; 2005 Mar; 4(2):117-25. PubMed ID: 15720960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
    Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
    Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.
    Agha H; El Tagui M; El Ghamrawy M; Abdel Hady M
    Ann Hematol; 2014 Jul; 93(7):1131-8. PubMed ID: 24562420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease.
    Sharma S; Efird J; Kadali R; Mehra S; Chohan H; Daggubati R; Liles D; Gouge C; Boettger P; Knupp C
    Clin Cardiol; 2013 Sep; 36(9):524-30. PubMed ID: 23893714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
    Detterich JA; Kato RM; Rabai M; Meiselman HJ; Coates TD; Wood JC
    Blood; 2015 Aug; 126(6):703-10. PubMed ID: 26036801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of sociodemographic, clinical, and laboratory markers of sickle leg ulcers among young nigerians at a tertiary health institution.
    Olatunya OS; Albuquerque DM; Adekile AD; Costa FF
    Niger J Clin Pract; 2018 Jul; 21(7):882-887. PubMed ID: 29984720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
    Klings ES; Anton Bland D; Rosenman D; Princeton S; Odhiambo A; Li G; Bernard SA; Steinberg MH; Farber HW
    Am J Hematol; 2008 Jul; 83(7):547-53. PubMed ID: 18383329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.